beta
GTXI
GTx Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
GTx Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of small molecules for treatment of cancer, including treatments for breast and prostate cancer and other medical conditions.
Market Cap: 254 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.gtxinc.com
Shares Outstanding: 21.5 Million
Float: 9.09 Million
Dividend: 0.0 (0.0%)
Beta: 1.574141
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1524 trading days
From: 2013-06-18 To: 2019-06-07
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2016-12-06 | 10.0 | 1.0 | 10.0 |